| ALGN |
Report |
Total revenue |
IN-LINE |
pred ~$1.055B vs. cons $1.051B |
MEDIUM |
| ALGN |
Report |
Clear-aligner cases |
IN-LINE |
pred ~687.0K vs. cons 683.2K |
MEDIUM |
| ALGN |
Report |
Non-GAAP diluted EPS |
BEAT |
pred ~$2.64 vs. cons $2.59 |
MEDIUM |
| ALGN |
Guide |
Q3 revenue (Q3'26) |
UNCHANGED |
guide ~$1.020B midpoint vs. cons $1.024B |
MEDIUM |
| ALGN |
Guide |
FY26 revenue growth |
UNCHANGED |
guide ~3%-4% vs. cons $4.180B |
MEDIUM |
| ALGN |
Guide |
North America retail commentary (Q3/FY) |
UNCHANGED |
mixed retail / strong DSO and international; quantified consensus UNVERIFIED |
LOW |
| ALGN |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.5% |
— |
LOW |
| ALGN |
Return |
5-day cumulative residual |
-5.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — unchanged framework leaves forward revisions constrained |
LOW |